CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 116 enrolled
Drug / intervention
5% nicotine +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05205382
NCT05205382N/ACompleted

Assessing the Effect of Nicotine Reduction on ENDS User's Addiction and Exposures

Florida International University·interventional·Posted Jan 25, 2022·Updated Sep 23, 2025

In Brief

A clinical study evaluating 5% nicotine, 3% nicotine, and 1 other intervention for Electronic Cigarette Use. Completed, enrolled 116 participants across 1 site.

Detailed Summary

The rapid increase of electronic nicotine delivery systems (ENDS) use by young people in the US and their potential to harm health, cause addiction, and serve as a risk for cigarette smoking or dual-use is alarming. The epidemic of ENDS use among young people in the US has been associated with the rise in popularity of ENDS products that are very efficient in delivering high doses of nicotine to users. Therefore, the investigators propose to study the effects of nicotine reduction (NR) on young ENDS users as a potential regulatory strategy to reduce the addictiveness and use of ENDS. The proposed studies are directly responsive to research priories identified by the FDA and specified in this RFA under Addiction; studying the "Impact of changes in tobacco product characteristics (e.g. nicotine formulation) on dependence". This project aims to provide an overview of this project's rationale significance divided into 1) scientific rationale and regulatory implications; 2) the need to respond to the rising trend of ENDS use among young people in the US; 3) the importance of reducing the addictiveness of ENDS; 4) the strength of our clinical and analytical lab approach for regulatory purposes; and 5) the strengths and weaknesses in the rigor of prior research about NR for ENDS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedJan 25, 2022
Enrollment StartApr 1, 2022
Primary CompletionApr 15, 2025
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 4.4 years ago

Interventions

5% nicotineother

Effects of e-cigarette pods (JUUL/NJOY/SREC) with 5% nicotine concentration nicotine concentration

3% nicotineother

Effects of e-cigarette pods (JUUL/NJOY) with 3% nicotine concentration

0% nicotineother

Effects of e-cigarette pods (SREC) with 0% nicotine concentration